The dynamics of the FAK inhibitor market is anticipated to change as companies across the globe are thoroughly working toward developing new FAK options with convenient RoA and better safety
Next-generation immunotherapies market is expected to grow significantly during the forecast period (2023-2032) owing to the increasing number of cancer cases in the 7MM, accompanied by the
The ovarian cancer market is expected to grow significantly owing to an increase in diagnosed cases, increased awareness about the disease, increased R&D for developing new molecules, and the
The ELISA market is expected to prosper due to factors such as the increasing prevalence of infectious diseases such as HIV, tuberculosis, malaria, and hepatitis B, among others, growing application
The nuclear medicine market is expanding rapidly due to the rising prevalence of cancer, cardiovascular disease, and other chronic diseases caused by an inactive lifestyle. Furthermore, the